Modulation of cyclophosphamide activity by o6-alkylguanine-dna alkyltransferase

Cancer Chemotherapy and Pharmacology

Volumn 43, Issue 1, 1999, Pages 80-85

  Friedman, Henry S ^a   Pegg, Anthony E ^b   Johnson, Stewart P ^a   Loktionova, Natalia A ^b   Dolan, M Eileen ^c   Modrich, Paul ^a   Moschel, Robert C ^f   Struck, Robert ^d   Brent, Thomas P ^e   Ludeman, Susan ^a   Bullock, Nancy ^a   Kilborn, Cynthia ^a   Keir, Steve ^a   Dong, Qing ^a   Bigner, Darell D ^a   Colvin, O Michael ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d SOUTHERN RESEARCH INSTITUTE   (United States)

^e St Jude Children's Research   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Alkylating agents; Antineoplastic agents; Cyclophosphamide; Drug resistance; Nitrogen mustard compounds

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; 6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; ACROLEIN; CARMUSTINE; CYCLOPHOSPHAMIDE; PHOSPHORAMIDE MUSTARD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DNA CROSS LINKING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CEREBELLAR NEOPLASMS; CHO CELLS; CRICETINAE; CYCLOPHOSPHAMIDE; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032962702     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050866     Document Type: Article

References (21)

1. 1. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248
2. 2. Bullard DE, Bigner DD (1979) The heterotransplantation of human craniopharyngiomas in athymic "nude" mice. Neurosurgery 4: 308
3. 3. Chaney SG, Sancar A (1996) DNA repair: enzymatic mechanisms and relevance to drug response. J Natl Cancer Inst 88: 1346
4. 2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res 44: 990
5. 5. Colvin M, Chabner BA (1990) Alkylator agents. In: Chabner BA, Collins JM (eds) Cancer chemotherapy: principles and practice. Lippincott, Philadelphia p 276
6. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci USA 87: 5368
7. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res 51: 3367
8. 8. Dong Q, Bullock N, Ali-Osman F, Colvin OM, Bigner DD, Friedman HS (1996) Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines. Cancer Chemother Pharmacol 37: 242
9. 9. Dong Q, Bullock N, Johnson S, Colvin OM, Bigner DD, Modrich P, Friedman HS (1997) A different DNA repair pathway confers drug resistance to 4-hydroperoxycyclophosphamide (4-HC) in human medulloblastoma D283. Proc Am Assoc Cancer Res 38: 523
10. 10. Friedman HS, Colvin OM, Skapek SX, Ludeman SM, Elion GB, Schold SC Jr, Jacobsen PF, Muhlbaier LH, Bigner DD (1988) Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents. Cancer Res 48: 4189
11. 11. Friedman HS, Colvin OM, Aisaka K, Popp J, Bossen EH, Reimer KA, Powell JB, Hilton J, Gross SS, Levi R, Bigner DD, Griffith OW (1990) Glutathione protects cardiac and skeletal muscle from cyclophosphamide-induced toxicity. Cancer Res 50: 2455
12. 12. Friedman HS, Colvin OM, Kaufmann SH, Ludeman SM, Bullock N, Bigner DD, Griffith OW (1992) Cyclophosphamide resistance in medulloblastoma. Cancer Res 52: 5373
13. 13. Friedman HS, Dolan ME, Moschel RC, Pcgg AE, Felker GM, Rich J, Bigner DD, Schold SC Jr (1992) Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. J Natl Cancer Inst 84: 1926
14. 6-methylguanine repair in human lung cells. In: Myrnes B, Krokan H, (eds) Repair of DNA lesions introduced by N-nitroso compounds. Norwegian University Press, Oslo, p 154
15. 6-methylguanine-DNA methyltransferase by various aldehydes in cultured human bronchial fibroblasts. Carcinogenesis 6: 1755
16. 6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation. Br J Cancer 66: 331
17. 6-benzylguanine to killing by N,N′-bis(2-chloroethyl)-N-nitrosourea. Cancer Res 56: 1578
18. 6-alkylguanine-DNA alkyltransferase in vivo by pretreatment with antineoplastic agents. Biochem Pharmacol 38: 929
19. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 50: 6119
20. 20. Preuss I, Thust R, Kaina B (1996) Protective effect of O6-methylguanine-DNA methyltransferase on the cytotoxic and recombinogenic activity of different antineoplastic drugs. Int J Cancer 65: 506
21. 21. Zon G, Ludeman SM, Brandt JA, Boyd VL, Ozkan G, Egan W, Shao K-L (1984) NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis-and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways. J Med Chem 27: 466